| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  BioTek Instruments BioTek is worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. Life Science instrumentation and automation and software. Type: | 1 | 0 | 1 | 184 |
 | Aseptix Health Sciences N.V. Aseptix Health Sciences is a global leader in next generation antimicrobials, specializing in novel and patented infection prevention products and technologies for medical, professional and consumer use. Aseptix’ sustainable antimicrobial technologies enable products to safely, effectively and quickly kill contagious pathogens and are used in a wide range of applications, industries and therapeutic areas. The Company markets its products and technologies through a combination of Aseptix branded and third party branded products, and licenses on its portfolio of patented technologies to global industry leaders in their markets. The corporate mission is to become the global alternative for user unsafe and … Type: | 0 | 0 | 0 | 6 |
 | SynBiotic SE [Automatic translation follows] MAKING CANNABINOIDS ACCESSIBLE What our ancestors knew instinctively and through centuries-old traditions is now increasingly proven by scientific research: the active ingredients of the Cannabis sativa plant, the so-called cannabinoids, show many positive effects when used for medical purposes, such as for chronic pain and epilepsy. But ingredients of the Cannabis sativa plant are also increasingly being used in the field of cosmetics and dietary supplements. Synbiotic SE aims to map the entire value chain of the Cannabis sativa plant for the benefit of people: from basic research to the synthetic production of these substances to the … Type: | 0 | 0 | 0 | 3 |
 | FARMALIDER GROUP Fabrica de Ideas Farmalider, S.A. is a private pharmaceutical company established in 1986 in Madrid, Spain. We specialize in research, development ,license and supply pharmaceutical product for areas as generics, prescription, OTC, consumer health care, value-added, Food Supplements. In addition, we identify new molecules for new chemical entity developments. Our products are currently approved by regulatory agencies in over 25 countries worldwide and marketed through strategic partners in each territory We have registered nearly 26 patents and continue to proactively seek projects where we can protect our innovations and technology. We have strong knowledge in several therapeutic fields including oncology, … Type: | 1 | 0 | 1 | 89 |
 | Nemaura Pharma Limited Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the … Type: | 0 | 0 | 0 | 36 |
 | Embla Leading the fight against obesity by helping people lose weight sustainably. The biggest lie in obesity care is that there are easy fixes. This is an industry addicted to over-simplification, misinformation and inauthentic stock photos. None of it is real. Weight loss is complicated because people are. It’s tied to genetics, personality, lifestyle, hormones, habits, relationships and psychology. Embla exists to challenge the world’s reductive approach to weight loss, to reduce the harm to people’s health and our health system. We do this by combining science, compassion and service excellence. Highly personalised weight loss care that works because it’s precisely … Type: | 3 | 0 | 2 | 57 |
 | Mithra Transforming Women’s Health Through Innovation Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra … Type: | 1 | 0 | 1 | 524 |
 |  BDD A World Class Drug Delivery Company BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority … Type: | 0 | 0 | 0 | 47 |
 | Celyad Oncology Developing Innovative Cell Therapies Against Cancer Celyad Oncology is a biotechnology company focused on the discovery and development of tecnhlologies and platform for chimeric antigen receptor T cell (CAR T) therapies. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com. Immuno-Oncology, Cancer, Immnotherapy, shRNA multiplex, and CAR T-cells Type: | 0 | 0 | 0 | 44 |
 | VRG Therapeutics Regional leader in preclinical R&D with a world-class protein evolution tech platform for CGT applications Our mission is to cure diseases via targets and MoAs that cannot be reached with traditional approaches. Leveraging our unique platform, we optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals. VRGT’s management and staff members were selected based on their international research experience and outstanding pharma industry achievements. Our people have outstanding professional expertise in preclinical/clinical R&D and scientific project management, pharmacology, business development and medical marketing. For years, they have worked in the most prestigious academic … Type: | 1 | 0 | 1 | 26 |
 | Mysthera Therapeutics Multilineage immune modulation. The next chapter in autoimmune diseases. Mysthera is a preclinical stage biotech start-up focused on developing first-in class, oral therapeutics to treat major unmet needs in autoimmune diseases. Our unique approach has potential to transform patient lives in a number of disease settings including glomerulonephritis, rheumatoid arthritis and inflammatory bowel disease. We are first to develop PIM kinase inhibitors as therapeutics for multi-lineage immune cell driven autoimmune diseases. The team are experts in PIM kinase and immunology. Mysthera was founded by Forty51 Ventures in Europe’s pharma/biotech hub, Basel, in Switzerland in early 2023. biotech, kinase inhibitors, autoimmune … Type: | 0 | 0 | 0 | 3 |
 | ANGLE The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. … Type: | 1 | 1 | 0 | 154 |
 | Amarin Corporation Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6 Cardiovascular Type: | 1 | 0 | 1 | 459 |
 | altizem [Automatic translation follows] I like it 😊 🔹 We are an operational consulting company specializing in the Life Sciences sector (pharmaceuticals, agri-food, medical devices, cosmetics and fine chemicals) of the MoOngy Group. We support our clients (Sanofi, Merck, Nestlé, LVMH, etc.) throughout the life cycle of a product, by mobilizing our consultant engineers and pharmacists. 🚀 Altizem represents an annual growth of +35%, a presence throughout France and strong values built around people. 🏆 We are ChooseMyCompany HappyAtWork and ImpactIndex 2022 certified. MoOngy is Ecovadis Gold accredited 🏆 🔥 Passion, Proximity, Performance & Commitment are the values that each Altizen … Type: | 32 | 0 | 32 | 140 |
 | ALBHADES [Automatic translation follows] Analytical Solutions for Health Products 💊💉 Expert in microbiology and physical chemistry, Albhades has been supporting the health product industries (pharmaceuticals, medical devices, cosmetics), the chemical and food industries since 2001. Its analytical capabilities combined with its consulting service offer a global solution to the needs of method development and validation, process validation and quality control of raw materials, finished products and packaging. Its multiple combination of expertise positions Albhades on a complete analytical offer including mineral chemistry, organic chemistry, NMR analysis, microbiology, cell biology, mechanical testing, stability studies and toxicology. Its strength lies in the personalized … Type: | 7 | 1 | 4 | 77 |
 | KOELIS Advancing Prostate Care KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment. Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full … Type: | 9 | 5 | 4 | 114 |
 | ProteoGenix Accelerate your way to the clinic ProteoGenix is a leading life sciences organization which provides services in molecular biology and immunology and in particular polyclonal and monoclonal antibody development, recombinant protein expression and purification, peptide synthesis as well as gene synthesis. ProteoGenix’s commitment to its clients is to ensure the access to comprehensive and integrated solutions to help our customers develop the tools they need to efficiently conduct their biology and research projects in a time effective manner. Beginning with the synthesis of the gene ProteoGenix develops all the materials required for immunoassay services. Proteogenix’s exceptional and functional expertise combined … Type: | 1 | 1 | 0 | 39 |
 | MD Start MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these … Type: | 0 | 0 | 0 | 4 |
 | Drugabilis CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is the President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization Type: | 0 | 0 | 0 | 7 |
 | DIVERCHIM CDMO API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. … Type: | 3 | 2 | 3 | 54 |
 | Yposkesi, an SK pharmteco company Partnering to bring your cell and gene therapies to life! ***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.*** Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi … Type: | 14 | 4 | 10 | 182 |
 | mymediks [Automatic translation follows] My medications, everywhere, on time, safely 🚀 mymediks has been the leader in specialized delivery of medications to individuals and healthcare professionals since 2016 and the 1st specialized network of healthcare delivery people. 🇫🇷 Thanks to our tools and know-how, we now support healthcare professionals in more than 12 French cities to deliver medications safely. 🧑💻 For more information: http://www.my-mediks.com Pharmacy, Medicines, Delivery, Health, Internet, Innovation, Startup, Business Developer, Transport, Patients, Transport, e-health, Pharmacy, and PDA Type: | 0 | 0 | 0 | 6 |
 | NanOlogy Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or … Type: | 0 | 0 | 0 | 8 |
 | Impel Pharmaceuticals Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism Type: | 1 | 1 | 1 | 51 |
 | Viridian Therapeutics, Inc. Framing the future of autoimmune diseases Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is … Type: | 2 | 1 | 2 | 149 |
 | Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: | 1 | 0 | 1 | 90 |
 | Shockwave Medical Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with … Type: | 2 | 2 | 1 | 1,263 |
 | Leuko Non-invasive white blood cell monitoring Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device. Medical Devices, Diagnostics, Medical Technology, Clinical Imaging, and Bioengineering Type: | 3 | 2 | 1 | 16 |
 |  Pear Therapeutics The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first … Type: | 13 | 4 | 1 | 36 |
 | Editas Medicine What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One … Type: | 6 | 0 | 1 | 336 |
 | Caribou Biosciences Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, and … Type: | 8 | 1 | 2 | 167 |
 | Sirenas Bringing you a new generation of health products inspired by marine biodiversity Over the last decade and working with experts and local communities, Sirenas has sustainably and ethically built one of the largest and most unique collections of marine organisms and plants from diverse ecosystems and geographies. From the deep sea to coral reefs and estuaries. We’ve run these samples through cutting edge and proprietary chemical extraction and analytics, and tested each one in over 70 in-vitro biological assays relevant to human health. The result is the largest repository of information connecting the unchartered chemistry of marine organisms to applications … Type: | 1 | 1 | 0 | 12 |
 | BIOLIFE4D Build a Heart. Save a Life. Pioneered by accomplished business leaders, guided by world-class biomedical and life science experts, and financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death worldwide. Leveraging advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation, this biotech company is committed to optimizing the process and technology around viable human organ replacement, and making it a safe, accessible, commercially viable, and cost-effective reality. Type: | 0 | 0 | 0 | 7 |
 | Freenome Outpacing cancer starts with early detection Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ … Type: | 10 | 3 | 4 | 445 |
 | Ligandal Ligandal is developing precision molecular therapeutics and targeted delivery technologies. Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. Given that increasingly complex disease states require precise and custom-tailored medicine, … Type: | 1 | 1 | 0 | 13 |
 | ECOVO Project manager within medical device and pharmaceutical industry. Type: | 0 | 0 | 0 | 2 |
 | RedDress Ltd. Healing Is In Our Blood RedDress, a private medical device company, developed a ground breaking, advanced wound care product, based on a patented technology to reproduce the natural process of the body to heal wounds. The company based in Israel, was founded in 2009 by Dr. Igal Kushnir, MD and Alon Kushnir and is focused on developing effective solutions that improve outcomes for patients. RedDress management has vast experience in bringing breakthrough medical ideas to successful commercialization. wound care, wound healing, tissue repair, chronic ulcers, diabetic foot ulcers, pressure ulcer , venous ulcers, burns, and wound dressing Type: | 1 | 0 | 1 | 36 |
 | Mi Terro® Engineer agricultural waste into high-value, low-cost, and scalable biomaterials to end microplastics and hunger. Mi Terro is a venture-backed advanced material company that engineers agricultural waste into high-quality, low-cost, and scalable biomaterials to end microplastics – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our technologies are patented and are USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim of maximizing the use of agricultural side streams (non-food feedstock) and certified biomasses. While bio-based, … Type: | 10 | 2 | 6 | 13 |
 | NAVAN Transforming Cell Therapy Engineering NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human stem & primary cells. The patented NanoStraw technology provides direct intracellular access into hard-to-transfect stem & primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost and technical difficulties) are eliminated, resulting in fewer, faster operational steps. For more information on NAVAN, please visit www.navanbio.com. Type: | 0 | 0 | 0 | 7 |
 | Paindrainer AB Complete RTM solution. Drug-free, medical device demonstrating improved quality of life and alleviation of chronic pain. Paindrainer® is the first drug-free, evidence-based digital medical device demonstrating improved quality of life and alleviation of chronic pain. The solution is powered by leveraging advanced algorithms and is fully adaptive to each user, a feature called 360° patient-centricity©. This feature is protected by a patent granted by the European Patent Office (EPO) for the unique proprietary platform that enables patient-centric chronic pain management. The Paindrainer® mobile application enables each user to manage their pain and provides guidance on how to achieve a personalized … Type: | 2 | 0 | 2 | 11 |
 | Aktiia Blood Pressure Intelligence for Global Health At Aktiia, we're at the forefront of revolutionizing blood pressure management and comprehension globally. Harnessing cutting-edge AI-powered algorithms on top of over 300 million data points collected from more than 60,000 active users across the globe, we foster breakthroughs in hypertension comprehension and tailored patient care. Aktiia's CE-marked platform is currently available in seven European markets and approved as a medical device in 44 countries worldwide. And we continue to accelerate our efforts to achieve better health for the world. AI, hypertension, digital therapeutics, healthcare, blood pressure, and patient management Type: | 2 | 0 | 2 | 57 |
 | SC MEDICA SC MEDICA is a medical Devices for Spinal Surgery company Type: | 1 | 1 | 0 | 7 |
 | SkinDermic Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. Type: | 0 | 0 | 0 | 5 |
 | The Twinkle Factory Stain Different. Tag FAST. The Twinkle Factory offers exclusive twinkling reagents for life science research: flurogenic ligands for FAST and split FAST, protein fluorescent reporters, and fluorogenic molecular glues for CATCHFIRE, a self reporting protein dimerizer. Protein-protein interactions, high content analysis, anaerobe metabolic engineering, are our users keywords. The Twinkle Factory is dedicated to speed-up the dissemination of breakthrough fluorescent technologies across the life sciences community. molecular glues, protein-protein interactions, and fluorescent proteins Type: | 0 | 0 | 0 | 6 |
 | ViroScan3D Solutions Personnalisées de Génomique ViroScan3D is a service provider in genomic and micro-genomic located in Lyon. We have ten year experience in genome scale analyses from sample preparation to data analysis. During those years we have developed specific processes dedicated to complex samples (low quality and quantity samples). We propose our services for -Molecular broad spectrum identification of infectious agents, new agents, resistance mutants by whole genome sequencing of viruses and microorganisms (bacteria, yeast, fungi, etc.) -Analysis of complex populations using the metagenome, virome, bacteriome approach to identify the different agents in the population and their proportions -The identification of … Type: | 0 | 0 | 0 | 2 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | BIOMILLENIA Microbiology assays at previously impossible speeds and strain banks with amazing diversity ! Microbiology is what we do. Our unrelenting focus has enabled us to develop unique capabilities in ultra-high-throughput single-cell culture of microorganisms. Businesses in areas as diverse as pharma, agriculture, food, human health and environmental protection have partnered with us to gain powerful competitive advantages from our technology.So could yours. Our proprietary microfluidic platform is capable of : - identifying microbes of interest based on their functional characteristics among millions of candidates - perform a wide range of assays at previously impossible speeds - generate strain banks with … Type: | 0 | 0 | 0 | 5 |
 |  Synens Intelligent Drug Screening Synens is a French company that manufactures rapid on-site drug screening devices. We strive to deliver reliable and customizable drug test kits and analyzers. At Synens, adaptability is key. We meet the requirements of our clients and the regulations in force. Synens is the designer of the D1 Handheld Analyzer that is used internationally by law enforcement, fire departments, healthcare professionals and in workplaces. Technology, Drug Screening, and Drug of Abuse Detection Type: | 0 | 0 | 0 | 1 |
 | SynHelix (now Quantoom Biosciences, a Univercells Company) Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology Type: | 2 | 2 | 1 | 122 |
 | OxiProteomics Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a technology-based start-up committed to promoting the healthy living and healthy aging of human population. We deliver proven science services to dermo-cosmetic and food industries to support marketing claims. We also offer environmental quality bio-monitoring solutions to promote sustainable development. OxiProteomics patented technologies are based on the direct and specific detection of functional high quality proteins vs. oxidatively damaged (carbonylated) in biological samples, with a remarkably specificity and sensitivity. We can detect and quantify for the first time, the quality of thousands proteins … Type: | 2 | 1 | 1 | 12 |
 | Alpioner Therapeutics Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens. Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR). Type: | 18 | 4 | 1 | 3 |
 | Natura Meliss' [Automatic translation follows] A zero-waste and natural bathroom “Mixed, healthy and effective products based on Ayurvedic plants” The idea of Natura Méliss’ was born after a 15-year experience as an engineer in a pharmaceutical Research and Development laboratory. I was not convinced by the cosmetics I found in stores. So I decided to look for solutions. I discovered Ayurvedic medicine a few years ago. Ayurveda, or Ayurvedic Medicine, is a therapeutic system created in India about 5000 years ago. In Sanskrit the word “Ayurveda” is a combination of two words “ayur”, which means “life” and “veda”, which means “science”. Thus … Type: | 1 | 1 | 0 | 1 |
 | GlycoBAR GlycoBAR: a new and cost effective way to get rid for blood group antibodies. No blood group barrier any more ! GlycoBAR sells blood group antigen ligands that can be used to make plasma "Universal" (=compatible with all recipients, whichever the blood group of the donor is). Our ligands are also allowing transplant of organs when donor and recipients are belonging to incompatible blood group Biofermentation, Blood purification, Blood group antibody removal, and Isoagglutinins removal Type: | 4 | 4 | 0 | 3 |
 | Hydroxide Technologies [Automatic translation follows] Design / Manufacturing of Fuel Cell Testing Equipment & Fuel Cell System Engineering Design / Manufacturing of Fuel Cell Testing Equipment & Fuel Cell System Engineering Hardware Electronics, Control/Command, Fuel Cell System, UI design, and Embedded System Type: | 2 | 0 | 0 | 4 |
 | NOXELIS Innovative ocular solutions Noxelis is a French ophthalmic medical device company dedicated in developing next-generation treatments, including polymers and hyaluronic acid as a cornerstone. Through its technological platform, Noxelis proposes different formulations aimed at improving medical practice and provides ophthalmologists with first-in-class therapies to treat ocular surface diseases. Noxelis was founded by a passionate and determined team to bring innovative technologies to market with one focus: Bring patients' ocular comfort to the next level. Type: | 2 | 2 | 0 | 4 |
 | G.CLIPS biotech ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization … Type: | 12 | 2 | 5 | 6 |
 | CLARTEIS Clarteis is a global specialist in the miniaturization and manufacture of medical devices dedicated to dermatology. CLARTEIS is a global leader in manufacturing advanced and innovative technologies for the Dermatological market. CLARTEIS team is specialized in developing miniaturized and high quality light-based medical devices to provide to Dermatologists worldwide. Type: | 0 | 0 | 0 | 11 |
 | AnatomikModeling 3D custom made implants AnatomikModeling creates 3D custom-made implants for Reconstructive&Aesthetic Surgery, Pneumology and Maxillofacial Surgery. Our 3D custom-made implants are designed for Pectus Excavatum, Poland Syndrome and others anatomy defects like hard or soft tissues loss. Medical Devices, Reconstructive surgery, Pectus Excavatum surgery, Poland Syndrome surgery, and 3D CAD CAM Medical implants Type: | 0 | 0 | 0 | 4 |
 | AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine Type: | 0 | 0 | 0 | 1 |
 | IPSOMEDIC Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes Type: | 2 | 0 | 0 | 16 |
 | Syntivia Preclinical and R&D expertise for skin health care Syntivia helps you access the latest innovations in science for your skin research. Our experts in skin biology test and develop new molecules, active ingredients and formulas using the latest tools and techniques in cellular biology, molecular biology, green chemistry, click chemistry and plant extraction. Our scientific expertise, hi-tech equipment and know-how takes into account the latest market tendencies and regulatory requirements of the cosmetics market and pharmaceutical reserach. Skin health care, High-tech imaging equipment, Evaluation of skin drugs and cosmetic ingredients, Skin Biology, Tissue & cell culture, Skin explant, Biotechnology, Human … Type: | 0 | 0 | 0 | 9 |
 | INFYNITY BIOMARKERS SAS Maximizing Immunoassays Performances InfYnity Biomarkers was founded in 2009 in Lyon (France). We are an R&D In-Vitro Diagnostics Company fully dedicated to infectious diseases and immunity. Company Mission: Maximizing Immunoassay Performance i.e. we have the ambition to set new criteria for immunoassays: study the diversity of immune response to provide high-value information instead of the binary response. Our Offer: - High quality, custom-made biomaterial (antigens and antibodies) - RUO Multiplex Immunoassays - Tailored immunobiology services ranging from biomaterial design to biomarker discovery and immunoassay development. Our originality and strength relies on a unique combination of proven skills: Multiplex technology AND … Type: | 0 | 0 | 0 | 7 |
 | GutyCare Digital therapeutics & patient monitoring solutions specialized in gastroenterology and immunology We develop Digital Support Programs and Digital Therapeutics for patients suffering from digestive pathologies (IBS, IBD, Cancer...) Type: | 4 | 2 | 2 | 7 |
 | Biomaneo, a Shimadzu group company [Automatic translation follows] A Shimadzu group company Biomaneo specializes in the design and marketing of innovative medical analysis kits based on the fine analysis of proteins by mass spectrometry for neonatal screening and the diagnosis of various pathologies in hospital laboratories. Screening and Diagnosis, Mass Spectrometry, Medical Device, and Biological Markers Type: | 0 | 0 | 0 | 14 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 2 | 1 | 1 | 12 |
 | VITROPEP To make syringe injections disappear! Vitropep customizes soluble microneedles patches made of biomaterials for transdermal injection Type: | 10 | 4 | 9 | 2 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 1 | 1 | 0 | 11 |
 | En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing Type: | 5 | 3 | 3 | 6 |
 | Cutting Edge SAS Over 20 years of experience dedicated to intraocular lenses manufacturing To design, develop and distribute innovative solutions in eye surgery contributing to patient well-being. We have over 20 years of experience dedicated to IOL manufacturing. Opthalmology, Intraocular Lenses, Medical Devices, Surgical, Cataract, Vitreoretinal, and Cornea Type: | 1 | 1 | 0 | 41 |
 | Altevax Biotech Altevax is developing a disruptive immunotherapy technology against cancer Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and … Type: | 11 | 3 | 5 | 6 |
 | AmyPore New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and other proteinopathies AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay … Type: | 1 | 1 | 0 | 1 |
 | Suricog SuriCog was founded in mid-2013 by Marc Massonneau, serial entrepreneur in medical devices & services, and some other passionate people, to develop new generation of gaze-based diagnostic tools in order to improve patient pathways in neurology and psychiatry. In 2016, we acquired a company which developed a 10M€ program for best-in-class eye-movement acquisition and analysis solutions in several key neurological diseases Drawing from over a quasi-decade of eye studies, algorithm development, optoelectronics design, high-end software, and clinical trials and applications, we have advanced our technology for integration in a data-driven complete solution, as the fundamental for medical oriented eye-tracking. The … Type: | 2 | 3 | 0 | 23 |
 | E-PHY-SCIENCE E-PHY-SCIENCE is a service company specialized in In-vivo and In-vitro electrophysiological assays. If you are currently developing a program in CNS disorder, we can help you increase your chances of success. By gathering on the same platform In-Vivo and In-Vitro electrophysiological assays, the E-PHY-SCIENCE team is able to offer you a complete range of studies. These assays can reveal specific abnormalities in many genetic models of human brain disease, as well as the effect of new molecules on normal brain functions. These types of experiment provide insights for new therapies as well as understandings of brain diseases mechanisms. We cover … Type: | 1 | 0 | 0 | 10 |
 | ProGeLife [Automatic translation follows] Innovative research solutions for rare diseases Development of drugs for the treatment of rare genetic diseases with premature or accelerated aging Type: | 0 | 0 | 0 | 9 |
 | ATLANTHERA Bone targeted delivery concept Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network Our concept: Bone-targeted delivery of anti-cancer drug www.atlanthera.com Watch our concept in video > https://youtu.be/m3BBWguO6hs Durg discovery, Bone-targeted drug delivery, Bone cancer, and Bone metastases Type: | 2 | 1 | 2 | 11 |
 | GOLIVER THERAPEUTICS Repair the liver without graft GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation. GOLIVER THERAPEUTICS aims to become a Worldwide leader inregenerative medicine in providing the first cell-based therapy product for life-threatening liver failures. Type: | 5 | 1 | 5 | 32 |
 | OCRvet Your partner for comparative medicine studies Oncovet Clinical Research (O.C.R.) is an innovative Contract Research Organization specialized in the conception and management of clinical trials on Dogs & Cats models with naturally occurring pathologies for efficacy assessment of drug candidates for Human Health. O.C.R. innovative offer is at the forefront of ethics of research involving animals since Dogs & Cats included in clinical trials benefit from new therapies developed for Human. O.C.R. main therapeutic fields are Oncology, Inflammation, Cardiology & Neurology. O.C.R. proposes to support Pharma & Biotech in furthering their drug development programs (in preclinical & clinical phases) by … Type: | 3 | 1 | 1 | 21 |
 | METAFORA biosystems AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, and research Type: | 17 | 2 | 12 | 34 |
 | LiMM Therapeutics LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells. LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes - to preserve health and treat inflammatory, infectious and metabolic diseases. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients. Type: | 0 | 0 | 0 | 5 |
 | EG 427 Pinpoint Gene Therapy At EG427 our unique, non-replicative Herpes Simplex Virus type 1 (HSV-1) based vector platform delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes to address prevalent diseases in neurology. Our lead asset EG110A, for the treatment of neurogenic bladder dysfunction, has received IND clearance in June 2024 from the US FDA. Our revolutionary approach to the treatment of this disease aims at providing patients with a comprehensive, long-term solution to their bladder management, through a highly selective molecular biology approach overcoming the drawbacks of current standard of care. Our HQ and labs are in … Type: | 2 | 2 | 0 | 23 |
 | Rarecells Detect and defeat cancer from its start through a simple blood draw. Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique … Type: | 1 | 1 | 0 | 20 |
 | Scipio bioscience Single-cell sequencing on every benchtop At Scipio bioscience we are passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio propels the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provides all researchers with Empowered Autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for the highest-quality results and true biological information. We will be glad … Type: | 2 | 1 | 1 | 28 |
 | Innoskel Developing novel therapies for rare bone diseases Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their … Type: | 7 | 6 | 0 | 11 |
 | Affluent Medical [Automatic translation follows] Addressing unmet needs in structural heart disease, vascular therapy and urology. Affluent Medical is a new French medtech player with the ambition of becoming a European leader in the cardiovascular and urological fields. Affluent Medical develops innovative, next-generation, minimally invasive implants to restore essential physiological functions in these fields: - Kardiozis aims to prevent endoleaks and the risk of abdominal aortic aneurysm recurrence, allowing patients to live more peacefully in the face of an unpredictable risk of rupture; - Kalios and Epygon aim to offer more physiological surgical treatments for the repair or replacement of the heart's … Type: | 3 | 2 | 1 | 69 |
 | Evora Biosciences First-in-class immunomodulatory peptides. Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need. immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation Type: | 4 | 3 | 1 | 7 |
 | Egle Therapeutics Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones. Type: | 1 | 1 | 0 | 37 |
 | Step Pharma Developing selective inhibitors of CTPS1 for patients with cancer and auto-immune diseases Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. Step Pharma’s lead program STP938 is a potent, selective, oral inhibitor of CTPS1 with demonstrated potent anti-tumor activity in models of leukemia and lymphoma. STP938 will enter clinical development in 2022 for the treatment of relapsed and refractory T-cell and B-cell lymphoma. Type: | 1 | 0 | 0 | 16 |
 | NUTRIFIZZ [Automatic translation follows] A pioneer, Nutrifizz is a scientific and technical design office that places health nutrition at the heart of research and innovation projects for players in the food chain. Created by two doctors in nutrition, Céline GRYSON and Emilie CHANSEAUME, Nutrifizz is committed to providing depth through science, to engage in future themes in the field of innovation by surrounding itself with the best partners. Our leitmotif: Co-constructing the resolution of the science, regulation, market equation! Beyond their cross-disciplinary knowledge, our project managers have specific scientific expertise in connection with the future challenges of nutrition such as plant … Type: | 11 | 6 | 8 | 6 |
 | MAbSilico The only TechBio providing computationally designed antibodies through AI with biological validations associated MAbSilico is a TechBio company developing and providing AI-based solutions for antibody drug design and discovery. We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated with state-of-the-art biological technologies. While MAbSilico combines 3D modeling, interaction simulation and linear sequences analysis, the antibody drug candidates are defined through their epitope, affinity, off-target risk, cross-species reactivity and developability assessment to be ready for biological activity evaluation. Using NLP technologies we gather information … Type: | 16 | 3 | 11 | 13 |
 | PureTech Health Giving Life to Science PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed … Type: | 11 | 0 | 5 | 109 |
 | PharmEnable Therapeutics Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, … Type: | 4 | 1 | 3 | 21 |
 | Hulptroepen Alliantie [Automatic translation follows] Auxiliary Alliance supplies personal protective equipment, rapid tests and antibody tests to healthcare organizations, companies and consumers. Type: | 1 | 1 | 0 | 3 |
 | Röchling Medical Medical plastics solutions for every patient, everywhere, every day We are a preferred supplier and development partner of leading pharmaceutical, biotech and medical technology companies worldwide. Under cleanroom conditions, we manufacture customized pharmaceutical packaging and delivery solutions, consumables for diagnostics, and sophisticated components and assemblies for medical devices. Our customers are pioneers in disease prevention and health restoration. As a reliable partner for integrated solutions, we help to keep it that way. At our sites around the world, we jointly develop innovative and customized plastic products, services, and platform solutions. As a family-owned company, we enable our customers worldwide to … Type: | 0 | 0 | 0 | 285 |
 | Anavex Life Sciences Anavex utilizes genomic biomarkers in precision medicine to treat severe neurological disorders Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study … Type: | 1 | 0 | 1 | 53 |
 | Cernostics Providing Deeper Tissue Insights Cernostics has joined Castle Biosciences. Please stay connected! https://www.linkedin.com/company/castle-biosciences-inc-/ Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform … Type: | 0 | 0 | 0 | 552 |
 | Bitome Better tools, faster science Bitome is a Boston-based life sciences tools company that uses metabolomic insights to drive efficient biomanufacturing. Bitome's magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment -- enabling bio-based products to get to market faster. Our mission at Bitome is to enable the bioeconomy with purpose made tools, so join us as we de-risk industrial biology. Magnetic Resonance, synthetic biology, continuous monitoring, metabolic analysis, lab automation, instrumentation, MEMS, microfluidics, and machine learning Type: | 0 | 0 | 0 | 2 |
 | ProsFit Our Vision: A world where innovation provides limb wearers a choice of affordable, reliable and desirable prosthetic products and services. Motivation: We aim to play our part in enabling confident mobility, timely rehabilitation, community inclusion, and social integration. Through smart deployment of crucial innovation we want to help build transparent health economics, and attract new talent into the industry. Business model: Supports prosthetic clinic owners to radically improve productivity and user outcomes. Innovation roadmap for transformation of prosthetic service delivery at a global scale. Implementation through scalable business model, sized to fit 20m amputees globally. PandoFit: Proprietary cloud-based cross-platform, modular … Type: | 0 | 0 | 0 | 8 |
 | NanoGenics Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. Nanogenics is proud to introduce LipTideTM; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver different payloads for all gene therapy. LipTideTM is a peptide nanoparticle that has already shown excellent in vivo efficacy across a range of models and delivery routes, including nebulised and systemic administration. The peptide component performs two functions: it binds the payload to form the core of the nanoparticle and it also triggers receptors on target cells, which cause the cell … Type: | 0 | 0 | 0 | 1 |
 | Draft Grupo de Comunicación Healthcare [Automatic translation follows] #BeDrafter #DraftHealthcare Communication group specialized in healthcare. More than 30 years committed to the health of brands and with a high knowledge of the environment in all therapeutic areas. We have a multidisciplinary team: doctors, chemists, pharmacists, publicists, journalists, photographers, economists, graduates in fine arts and audiovisual communication. More than 20 professionals sharing knowledge and providing global solutions in specialized communication in health and medical devices. The group is made up of three divisions that join forces to ensure a global, complete and comprehensive response. Draft Advertising: The advertising and communication agency. Draft G5: Division specialized in … Type: | 1 | 1 | 0 | 31 |
 | Nanordica Medical First-in-class wound dressings with nanotechnology aiming to prevent clinical infection and promote wound closure. Nanordica Medical is an Estonian MedTech company. We are pioneers in advanced antibacterial nanotechnology preventing and curing topical bacterial infections. The company applied for several international patents and develops its first product, an advanced antibacterial wound dressing. A pilot clinical trial in the largest Estonian hospital showed Nanordica's wound dressing cures wounds that can not be cured with other methods and causes fewer adverse effects compared to the current leading antibacterial dressing. Our long-term goal is to be a world-wide renowned global deep tech company developing … Type: | 1 | 0 | 0 | 11 |
SMB